BioSpace News Archive

Bill Leonard, President and Chief Executive Officer and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. on March 11, 2020 to discuss the financial results for the quarter.

Former Reach Surgical entrepreneurs Richard Fang and Daniel Teo launches new fund to develop Intelligent technologies for surgical devices

Avellino Labs, global biotechnology and precision medicine innovators, announced that Chris Lehman has joined the company as Chief Financial Officer.

OSE Immunotherapeutics announced that the Japanese Patent Office has issued a new patent family related to Tedopi®, a combination of neoepitopes, protecting the product’s method for inducing early T-lymphocyte memory response for use in the treatment of cancer in HLA-A2 positive patients.

Horizon Discovery Group plc announced that it will provide access to a novel base editing technology licensed from Rutgers, The State University of New Jersey, for exclusive use in therapeutic, diagnostic and services applications.

Athersys, Inc. announced the one-year follow-up summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell therapy to treat patients who are suffering from acute respiratory distress syndrome.

The American Academy of Ophthalmology urges people at risk to be screened for this potentially blinding eye disease

Takeda Pharmaceutical Company Limited will provide an update on the progress of its business transformation and priorities at the 38th Annual J.P. Morgan Healthcare Conference.

Teleflex Incorporated (NYSE: TFX) recently hosted urologists from around the world to review clinical data and share best practices for using the UroLift® System to improve the care of patients with an enlarged prostate, or benign prostatic hyperplasia (BPH).

Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by introducing lower-priced versions of Humalog® Mix75/25™ KwikPen® (insulin lispro protamine and insulin lispro injectable suspension 100 units/mL) and Humalog® Junior KwikPen® (insulin lispro injection 100 units/mL).